Centene Boosts Specialty Drug Expertise With Pair of Deals
Centene Corp. celebrated the end of 2020 by closing on its acquisition of specialty pharmacy PANTHERx Rare, LLC on Dec. 30, then started 2021 with an agreement to acquire Magellan Health, Inc. The deals will strengthen Centene’s expertise in the specialty pharmacy space, particularly in the burgeoning orphan drug space by bringing onboard PANTHERx, an experienced company that’s shown remarkable growth over the past 10 years.
Centene and PANTHERx did not disclose terms of the deal, which was unveiled Dec. 15.
© 2024 MMIT